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Herpes simplex virus (HSV) is a DNA virus with tropism for infecting skin and mucosal
epithelia during the lytic stages of its complex life cycle. The immune system has evolved
a multitude of strategies to respond to primary HSV infections. These include rapid innate
immune responses largely driven by pattern recognition systems and protective anti-viral
immunity. Dendritic cells (DC) represent a versatile and heterogenic group of antigen
presenting cells that are important for pathogen recognition at sites of infection and for
priming of protective HSV-speciﬁc T cells. Here we will review the current knowledge on
the role of DCs in the host immune response to primary HSV infection. We will discuss
how DCs integrate viral cues into effective innate immune responses, will dissect how
HSV infection of DCs interferes with their capacity to migrate from sites of infection to the
draining lymph nodes and will outline how migratory DCs can make antigens available to
lymph node resident DCs. The role of distinct DC subsets and their relevant contribution
to antigen presentation on MHC class I and MHC class II molecules will be detailed in
the context of T cell priming in the lymph node and the elicitation of effector function in
infected tissues. An improved understanding of the fundamental mechanisms of how DCs
recognize HSV, process and present its antigens to naïve and effector T cells will not only
assist in the improvement of vaccine-based preventions of this important viral disease, but
also serves as a paradigm to resolve basic immunological principles.
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INTRODUCTION
Herpes simplex virus (HSV) type 1 and 2 are α-herpesviruses
of the herpesviridae family, representing one of the most fre-
quently encountered infections in humans (Koelle and Corey,
2008). InfectionswithHSV typically commence as the virus comes
into contact with deeper layers of the epithelium that line the skin,
the cornea or the mucosal tissues of the anogenital region through
small injuries. HSV enters these cells either by fusing directly with
the cell membrane or by translocating into the cytosol following
endocytic uptake. Infection of individual cells not only gives rise
to multiple newly formed virions that can then spread to other
cells, but also causes signiﬁcant damage to the infected cells that
historically is referred to as a cytopathic effect. These changes
include enlargement and disaggregation of the nucleolus, chro-
matin damage, destabilization of the cytoskeleton, insertion of
viral glycoproteins into organellemembranes and a global decrease
in macromolecular synthesis. The resulting death of multiple
infected cells leads to the destruction of the epithelial layer of the
skin, mucosa, or cornea. In the context of the skin, accumulation
of interstitial ﬂuid between the dermo-epidermal junction results
in the development of the characteristic blisters associated with
cold sores.
Symptoms of primary HSV infection are usually mild and
self-limiting. However, infections of individuals with acquired
or inherited immune defects can result in life-threatening dis-
ease (Sancho-Shimizu et al., 2011). This highlights the paramount
importance of immune control of HSV infected cells and tissues.
As with many intracellular infections, effective immune control of
HSV relies on the activation of cytotoxic lymphocyte responses,
among which HSV-speciﬁc cytotoxic T cells (CTL) are partic-
ularly potent (van Lint et al., 2004; Gebhardt et al., 2013; Shin
and Iwasaki, 2013; Zhu et al., 2013). Before HSV-speciﬁc CTLs
can seek and destroy infected cells, the few circulating naïve,
antigen-speciﬁc CTLs need to be activated in secondary lym-
phoid organs by dendritic cells (DC). In the case of murine
HSV skin infections this occurs in the local draining lymph
node (Bedoui et al., 2009b). With the primary reservoir of viral
antigens located in the epithelial layer of the affected organ,
migratory DCs capable of delivering antigens from the periphery
to the lymph node therefore play a crucial role in the initia-
tion of antiviral cell-mediated immunity (Zhao et al., 2003; Allan
et al., 2006; Bedoui et al., 2009b; Lee et al., 2009; Frank et al.,
2012).
The aim of this review is to summarize our current knowledge
on how DCs located at sites of primary HSV infection respond
to the virus, how this interaction impacts on their capacity to
migrate to the local draining lymph node and what role different
DC subsets play in the initiation of virus-speciﬁc T cell responses.
Not withstanding the distinct importance of HSV infections pro-
gressing into latency (Roizman and Whitley, 2013) and evidence
suggesting an interesting role forDC–Tcell interactions in the con-
text of neuronal HSV infections (St Leger and Hendricks, 2011),
we will focus on the events that take place during the lytic stage of
primary, extra-neuronal HSV infections.
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PIVOTAL ROLE FOR DCs IN THE CONTROL OF PRIMARY HSV
INFECTIONS
It is now well established that DCs consist of multiple subsets
that differ in phenotype and function (Heath and Carbone, 2009;
Reizis, 2012; Merad et al., 2013). Non-lymphoid organs contain
at least two types of conventional DCs that are characterized by
the expression of either CD11b or CD103 (Heath and Carbone,
2013; Malissen et al., 2014). The epidermis harbors an additional
DC subset, the Langerhans cells (LC; Kaplan, 2010). It was ini-
tially thought that LCs are the only DC subtype expressing the
C-type lectin langerin in the skin, but it was more recently appre-
ciated that CD103+ DCs also express langerin (Merad et al., 2008).
Common to these DC subsets in peripheral, non-lymphoid tissues
is their capacity to depart the tissue of origin, enter lymphat-
ics, and migrate to local lymph nodes, which is why these DCs
are often referred to as migratory DCs. Apart from migratory
DCs entering the lymph nodes via afferent lymphatics, lymphoid
organs also contain a separate, locally resident DC population
that can be further classiﬁed into CD11bhi and CD11blo sub-
sets. The CD11blo subset contains CD8+ DCs in mice and human
blood-dendritic cell antigen (BDCA3)+ DCs in humans (Bachem
et al., 2010; Crozat et al., 2010a; Shortman and Heath, 2010).
An important distinction between resident and migratory DCs
is therefore that only migratory DCs collect antigens in non-
lymphoid-tissues, such as the skin, while resident DCs are limited
to accessing antigens within the particular lymphoid tissue they
occupy. Plasmacytoid DCs (pDC) differ substantially from migra-
tory and resident DCs. While their direct contribution to T cell
priming during viral infections remains controversial, it is well
established that pDCs are very efﬁcient at secreting key antiviral
cytokines, such as interferon (IFN)-α/β (Villadangos and Young,
2008). In addition to conventional DCs and pDCs, inﬂammation
can also drive the in situ differentiation of CCR2+ Ly6Chi mono-
cytes into inﬂammatory or monocyte-derived DCs (Mo DC) both
in the periphery and lymphoid organs (Dominguez and Ardavin,
2010).
INNATE RECOGNITION OF HSV BY DCs
The early lytic phase of HSV skin infection brings into play the
immune system. The viral insult and the resulting tissue damage
not only evoke an inﬂammatory response leading to neutrophil
inﬂux (Stock et al., 2014) and release of pro-inﬂammatory medi-
ators (Eidsmo et al., 2009; Puttur et al., 2010), but also activate
epidermal LCs and dermal CD11bhi DCs (dermal DC). Equipped
with a broad suite of pattern recognition receptors, DCs are very
effective at detecting pathogens and pathogen-associated molecu-
lar patterns (PAMP). Several studies have therefore examined the
ability of DCs to recognize HSV and assessed how this recognition
leads to the secretionof key anti-viral cytokines. For example, it has
been demonstrated that in vitro exposure of bone marrow-derived
DCs (BM DC) to HSV results in the secretion of IL-6 and IL-12
(Sato et al., 2006). Interestingly, this release of IL-6 and IL-12, at
least in response to some HSV substrains, appeared to be regu-
lated by the consecutive stimulation of toll-like receptor (TLR)
2 through viral glycoproteins, such as gH/gL or gB (Leoni et al.,
2012), and endosomal TLR9 by viral DNA (Sato et al., 2006). HSV
recognition by DCs also elicits the release of IFN-α/β which exert
potent antiviral activities such as blocking immediate-early HSV
gene expression, preventing release of virions from infected cells,
and limiting progression of the infection from peripheral tissues
to the nervous system (Noisakran and Carr, 2001). Accordingly,
stimulation of IFN-α/β secretion is crucial for effective control
of HSV infections, as mice lacking the receptor for IFN-α/β are
unable to prevent spread of the virus upon primary infection into
the central nervous system (Halford et al., 1997; Leib et al., 1999;
Conrady et al., 2012). Although pDCs generally represent a major
source of IFN-α/β (Villadangos and Young, 2008) and trigger-
ing of TLR9 by HSV elicits IFN-α/β secretion from pDCs (Lund
et al., 2003), the relative importance of pDCs seems to depend
on the route of HSV inoculation. Vaginal infections (Lund et al.,
2006), and to a much lesser degree systemic infections (Swiecki
et al., 2013), require pDCs for effective HSV control. However,
the absence of pDCs has no impact on viral control following
cutaneous infections (Swiecki et al., 2013). These reports together
with the demonstration that a lack of myeloid differentiation pri-
mary response gene 88 (MyD88), which is a crucial downstream
adaptor molecule required for TLR2 and TLR9 signaling, had
no effect on HSV replication following subcutaneous or corneal
infections (Conrady et al., 2012; Swiecki et al., 2013) imply that
alternative pattern recognition receptors also play a signiﬁcant part
in translating HSV recognition into IFN-α/β responses. Recent
ﬁndings suggest that HSV induces IFN-α/β through a cytosolic
DNA sensor system that involves the adaptor molecule stimu-
lator of IFN genes (STING; Ishikawa et al., 2009). Although we
are only beginning to unravel the upstream sensor molecules
that utilize STING to drive IFN-α/β responses, recent in vitro
evidence indicates that HSV-induced IFN-α/β secretion by BM
DCs requires the Asp-Glu-Ala-Asp (DEAD) box helicase DDX41
(Zhang et al., 2011) and/or guanosine monophosphate–adenosine
monophosphate synthase (cGAS; Sun et al., 2013; Wu et al., 2013).
Gamma-IFN-inducible protein (IFI) 16, and itsmurine equivalent
IFI-p204, also appear to be likely candidates that linkHSV recogni-
tion to STING-dependent IFN-α/β responses (Unterholzner et al.,
2010; Conrady et al., 2012). In conjunction the available data sug-
gests thatDCs respond toHSV throughmembrane-bound pattern
recognition receptors, such as TLR2 and TLR9, and via STING-
dependent cytosolic recognition pathways. Considering that DCs
can be infected with the virus (see below) and that viral replica-
tion exposes the cytosol to viral PAMPs, it is tempting to speculate
that the activation of cytosolic receptors largely occurs in DCs
that are infected with the virus, while engagement of endoso-
mal TLRs results from uptake of virus-containing material by
the DCs.
While the above has focused on how distinct pattern recogni-
tion receptors contribute to innate responses by DCs upon HSV
recognition, emerging evidence suggests that alternative, pattern
recognition receptor-independent pathways might also play a role
in innate activation during virus infection. For example, it has
been demonstrated that exposure of cells to viruses can result in
replication-independent disruptions of membrane integrity and
alterations of the cytoskeletal architecture that lead to IFN reg-
ulatory factor (IRF) 3 activation and IFN-α/β production (Hare
and Mossman, 2013). It will be intriguing to determine how such
pattern recognition receptor-independent physical alterations that
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occur in DCs encountering HSV contribute to their innate
immune activation.
MIGRATORY IMPEDIMENT OF HSV-INFECTED DCs
The interaction between HSV and DCs can also result in pro-
ductive infection of DCs. This has been demonstrated in murine
experiments, where LCs, dermal DCs, and CD103+ DCs emi-
grating ex vivo from HSV infected skin explants produced HSV-
encoded non-structural virus-derived proteins, such as infected
cell protein (ICP) 8, that require de novo synthesis (Puttur et al.,
2010). Consistent with this, several studies using murine BM DCs
or human DCs grown from blood monocytes have shown that
DCs can be productively infected with HSV in vitro. Remark-
ably, although HSV-infected DCs are present in primary HSV
skin lesions (Eidsmo et al., 2009) and migration of DCs to the
draining lymph node is dramatically increased in response to
the infection (Allan et al., 2006; Bedoui et al., 2009b; Puttur
et al., 2010), productively infected DCs could not be detected
in lymph nodes draining the site of infection (Eidsmo et al.,
2009). Together with transfer studies of in vitro infected and
control BM DCs showing that infected DCs are signiﬁcantly
impaired in migrating from subcutaneous tissues into the lymph
node (Eidsmo et al., 2009), it seems that HSV-infected DCs are
excluded from, or are at least impaired, in migrating from infected
skin to the lymph node. Although deﬁnitive in vivo evidence is
pending, in vitro studies suggest that this lack of infected DCs
reaching the lymph nodes could be due to a combination of
different effects the virus exerts on infected DCs. Previous stud-
ies have shown that in vitro HSV-infected human Mo DCs had
reduced chemotactic abilities to follow CCL19 gradients and dis-
played enhanced attachment to ﬁbronectin (Theodoridis et al.,
2011). The authors suggested that enhanced ﬁbronectin bind-
ing required viral gene transcripts that block cytohesin-1 activity,
thereby increasing lymphocyte function-associated factor (LFA)
1 mediated adhesion to extracellular matrix (Theodoridis et al.,
2011). In addition to these integrin-mediated mechanisms poten-
tially retaining infected DCs in the skin, other molecules that
regulate the departure of DCs from the skin also appear to
be manipulated by HSV. Skin-residing LCs express high levels
of E-cadherin that tightly connect these to keratinocytes. To
depart the skin and enter the lymphatics, LCs not only need
to upregulate expression of CCR7 to follow the CCL19/21 gra-
dients present in the lymph, but also require downregulation
of E-cadherin to be released from keratinocytes (Jiang et al.,
2007). It was reported that although most LCs obtained from
HSV-infected skin downregulated E-cadherin, those infected with
HSV retained high expression levels of E-cadherin (Puttur et al.,
2010). As the retention of surface E-cadherin occurred only in
the presence of live but not UV-inactivated virus, the authors
concluded that de novo viral gene expression rather than uptake
of dead virus by the DCs was responsible for this. While these
studies did not observe major differences in the upregulation of
CCR7 between infected and uninfected LCs in HSV-infected skin
explants, in vitro experiments revealed that HSV-infected human
Mo DCs were impaired in their ability to respond to CCL19 (Salio
et al., 1999) and failed to fully upregulate CCR7 (Prechtel et al.,
2005).
APOPTOSIS OF HSV-INFECTED DCs
Impaired migratory behavior does not appear to be the only
means that impedes infected DCs from arriving in lymph nodes,
as in vitro HSV infections revealed that infected DCs also die
more rapidly than controls. Although this was initially believed
to be due to the cytopathic effects of the virus, it is now appre-
ciated that HSV can cause apoptosis of infected cells (Nguyen
and Blaho, 2007). In vitro studies revealing that inhibitors of pro-
tein synthesis prevented HSV-induced apoptosis have led to the
concept that the virus actively initiates apoptotic cascades. Con-
sistent with these studies that were largely conducted in Vero or
HeLa cells (Nguyen and Blaho, 2007), in vitro HSV infections of
human, macaque, and murine Mo DCs or BM DCs also result in
caspase-3 activation and signiﬁcant DC death (Jones et al., 2003;
Peretti et al., 2005).WhetherHSV-inducedDCdeath resulted from
the transcription of viral genes that actively induced apoptosis
is not entirely clear as some studies found that UV-inactivation
abrogated the ability of HSV to kill infected DCs (Jones et al.,
2003), while others reported that UV-inactivated virus was still
capable of inducing apoptosis in DCs (Stefanidou et al., 2013).
Regardless of the underlying molecular events, it is clear that HSV-
infected DCs can be driven into apoptotic cell death following
infection.
Overall, a picture emerges in which infected DCs are pre-
vented from migrating from infected tissues to the local draining
lymph nodes (Figure 1). As uninfected DCs still migrate from
infected sites, this phenomenon is most likely related to selective
migratory impairments in infected DCs, which on a func-
tional level are associated with sustained retention in the skin,
poorer responsiveness to chemokine gradients and induction of
apoptosis.
FIGURE 1 | HSV-infected DCs are retained in the skin and excluded
from migrating to the lymph node. Skin DCs, such as Langerhans cells
(LC), dermal DCs, and CD103+ DCs, can be productively infected in
HSV-infected skin. This leads to their retention in the skin and induction of
apoptosis. Debris from dying or dead infected cells will be taken up by
uninfected migratory DCs that then depart the skin to transport the
antigens to the lymph node via afferent lymphatics.
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STIMULATION OF HSV-SPECIFIC CTLs BY DCs IN THE LYMPH
NODE
A central role of DCs in viral infections is to activate naïve antigen-
speciﬁc CTLs in the lymph node. Following the conversion of
naïve CTLs into effector cells, these migrate into the tissues, where
they actively contribute to reducing the number of infected cells,
such as keratinocytes. Several studies have demonstrated that DCs
isolated from the lymph nodes draining the site of HSV infec-
tion can efﬁciently stimulate virus-speciﬁc T cell responses (Zhao
et al., 2003; Allan et al., 2006; Bedoui et al., 2009b). Analysis of
the different DC subtypes present in murine lymph nodes fol-
lowing epidermal HSV infection revealed that early presentation
of HSV-derived, MHC class I-restricted antigens was restricted
to lymph node-resident CD8+ DCs (Allan et al., 2003) and even
its CD24+ CD8− precursors (Bedoui et al., 2009a). Together with
comparable results obtained in a model of vaginal HSV infection
(Zhao et al., 2003), these ﬁndings challenged the prevailing view
at the time that skin-derived DCs would not only collect anti-
gens in the skin and transport it to the lymph node, but were
also responsible for presenting it to naïve CTLs (Carbone et al.,
2004). A subsequent study revealed that pharmacological block-
ade of DC migration from skin to the lymph node impaired CTL
priming in response toHSV skin infection (Allan et al., 2006). This
indicated that although lymphnode-residentDCswere key toCTL
priming, their ability to present HSV-derived antigens on MHC
class I molecules still depended on the immigration of migra-
tory DCs from the site of infection. As pharmacological blockade
should not affect potential passive drainage of free virions from
the skin to the lymph node, these insights also imply that MHC
class I presentation by lymph node-resident CD8+ DCs was not
a consequence of drained virus actively infecting CD8+ DCs in
the lymph node (Figure 2). Consistent with this conclusion, free
virions could only be detected in lymphatics after HSV infection
via the subcutaneous route, but not following epithelial inocula-
tion (Lee et al., 2009). Thus, rather than CD8+ DCs displaying
antigens on MHC class I molecules as a result of direct presen-
tation, the suggestion was that antigens collected in the skin by
migratory DCs were passed on to CD8+ DCs in the lymph node
(Carbone et al., 2004). The exact mechanism enabling CD8+ DCs
to receive antigens frommigratoryDCs is still enigmatic, but could
potentially involve active transfer of antigens between the two cells
via exosomes (Thery et al., 2009) or gap junctions (Mazzini et al.,
2014). The observation that HSV-infected DCs readily undergo
apoptosis also opens up the possibility that CD8+ DCs access
viral antigens in the lymph node by phagocytosing cellular debris
from HSV-infected migratory DCs that have died in the skin or en
route to the lymph node. This view is consistent with in vitro stud-
ies showing that uninfected human Mo DCs can engulf material
from apoptotic, HSV-infected Mo DCs and subsequently present
the collected antigens to HSV-speciﬁc CTLs (Bosnjak et al., 2005).
The notion of transfer of antigens from DCs originating from
the site of infection to immature DCs residing in the draining
lymph node has interesting implications. For example, it likely
represents a means through which antigens collected by a single
DC at the site of infection can be distributed over multiple lymph
node resident CD8+ DCs, essentially enabling a greater number
of DCs to present the peripherally collected antigens to cognate
FIGURE 2 | Access of viral antigens to MHC class I and MHC class II
antigen presentation pathways.There are two principle sources from
which viral antigens can be delivered into the antigen presentation
machineries. Viral antigens can be derived either from within the cytosol of
productively infected cells (A) or via ingestion of viral debris or
virus-infected cells (B). The presentation of cytosolic antigens on MHC
class I molecules requires proteasomal degradation and subsequent
transport of the generated peptides into the endoplasmatic reticulum (ER)
via the transporter associated with antigen processing (TAP). In the ER,
peptides are loaded onto MHC class I molecules and trafﬁcked in vesicles
to the cell surface via the Golgi apparatus. This pathway is typically referred
to as “direct presentation.” Peptides for loading onto MHC class I
molecules can also be generated from exogenous proteins that have been
engulfed by the cell in a process termed “cross-presentation.” For this to
occur the exogenous proteins contained within endosomes need to be
unfolded, which likely involves gamma-interferon-inducible lysosomal thiol
reductase (GILT), before being translocated into the cytosol. Once in the
cytosol they can be fed into the MHC class I presentation pathway as
outlined for cytosolic antigens. The endosomal content also provides the
major source for antigens that are loaded onto MHC class II molecules. It
should be noted, however, that this is a very simpliﬁed view of the
processes underlying cross-presentation. More detailed descriptions can
be found elsewhere (Joffre et al., 2012; Nair-Gupta and Blander, 2013).
naïve T cells. Transfer of antigens can also be viewed as a strategy
to overcome some of the sophisticated immune evasion strate-
gies that HSV has evolved during its long co-existence with the
human host. For example, by ensuring that antigens “escaping”
from dying HSV-infected DCs are made available for presentation
by uninfected DCs, the capacity of HSV to drive infected DCs into
apoptosis becomes biologically less relevant for the induction of
protective CTL responses. Similarly, it could be argued that the
transfer of antigens counteracts the very effective ability of HSV to
interfere with expression and peptide loading of MHC molecules
by infected cells (Piguet, 2005).
CROSS-PRESENTATION OF HSV-DERIVED ANTIGENS BY DCs
Thenotion thatCD8+ DCs take up virally infectedmaterial, rather
than being directly infected, implies that HSV-speciﬁc CTL prim-
ing relies on DCs shunting exogenous antigens into the MHC
class I presentation pathway (Figure 2) in a process referred to
as cross-presentation (Ackerman and Cresswell, 2004; Kurts et al.,
2010; Segura and Villadangos, 2011; Joffre et al., 2012; Nair-Gupta
et al., 2014). Support for the relevance of cross-presentation in
this context comes from the observation that HSV infection of
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mice lacking gamma-IFI lysosomal thiol reductase (GILT) results
in impaired HSV-speciﬁc CTL responses (Singh and Cresswell,
2010). As GILT-deﬁcient DCs can only present HSV-derived anti-
gens to CTLs when directly infected with HSV, but not upon
exposure to HSV-infected bystander cells, defective CTL priming
in GILT-deﬁcient mice is consistent with a selective defect in cross-
presentation (Singh and Cresswell, 2010). The ability of CD8+
DCs to cross-present HSV-derived antigens was further shown
in vitro by exposing uninfected CD8+ DCs to bystander cells that
were infected with gH- or gB-deﬁcient HSV mutants (Jirmo et al.,
2009). The gH/gB-deﬁciency incapacitated the virus from form-
ing infectious virions, ensuring that productive infection only
occurred in the bystander cells, but not the CD8+ DCs. As the
bystander cells were chosen so they themselves could not present
the antigens, the proliferation of HSV-speciﬁc CTLs observed in
these in vitro experiments could therefore be attributed to CD8+
DCs cross-presenting antigens that they had engulfed from the
infected bystander cells. These ﬁndings together with impaired
HSV-speciﬁc CTL priming in mice lacking CD8+ DCs due to the
absence of the transcription factor basic leucine zipper transcrip-
tion factor, ATF-like 3 (batf3; Nopora et al., 2012) emphasize that
cross-presentation could be an important means by which CD8+
DCs stimulate HSV-speciﬁc CTL responses.
Interestingly, uptake of debris from dying or dead, HSV-
infected cells not only serves to deliver antigens, but also appears
to provide crucial innate signals to the CD8+ DCs. Following HSV
skin infection, the ability of CD8+ DCs to propagate effective CTL
priming was shown to depend on their expression of TLR3 and
TIR-domain-containing adapter-inducing IFN-β (TRIF), while
other TLRs that signal through MyD88 were dispensable (Davey
et al., 2010). Considering the endosomal location of TLR3 (Schulz
et al., 2005), and the fact that HSV-encoded viral RNA interme-
diates are abundant in HSV-infected cells (Weber et al., 2006), it
appears likely that the TLR3 pathway is engaged in CD8+ DCs as
they engulf debris from HSV-infected cells. How TLR3-mediated
stimulation in CD8+ DCs subsequently contributes to more efﬁ-
cient HSV-speciﬁc CTL priming remains to be resolved. However,
in this context it is noteworthy that in vitro equivalents of mouse
CD8+ DCs secrete IFN-λ in response to HSV-1 exposure and that
poly(I:C)-induced IFN-λ production depends on the presence of
TLR3 (Lauterbach et al., 2010). It is therefore possible that IFN-λ
might be an important downstream element of the TLR3 response
that enables CD8+ DCs to primeHSV-speciﬁcCTL responseswith
optimal efﬁciency.
Thus, there are several lines of evidence in support of the
view that CD8+ DCs gain access to viral antigens from exoge-
nous sources rather than as a consequence of being productively
infected (Figures 2 and 3). However, deﬁnitive proof that cross-
presentation is required for HSV-speciﬁc CTL priming is missing
and the relative contribution of direct and cross-presentation to
the overall magnitude of anti-viral T cell immunity still remains
to be unraveled.
MHC CLASS II-RESTRICTED PRESENTATION OF HSV
ANTIGENS BY DCs
It is thus plausible that CD8+ DCs receive HSV antigens from
migratory DCs in the lymph node. However, reducing the role
FIGURE 3 |Transfer of antigens from migratory DCs to lymph
node-resident CD8+ DCs. Dermal DCs, arriving in the lymph node draining
the site of HSV skin infection, present antigens to CD4+ T cells.
Interestingly, dermal DCs themselves are inefﬁcient at presenting the
collected antigens to HSV-speciﬁc CTLs. Instead, they transfer their
antigenic cargo to lymph node-resident CD8+ DCs that subsequently
present these to both HSV-speciﬁc CD4+ T cells and CTLs. Notably, by
optimizing the capacity of CD8+ DCs to present HSV-derived antigens on
MHC class I molecules, the CD4+ T cells also assist in augmenting the
overall CTL response to the infection.
of migratory DCs during HSV skin infections to that of simple
providers of antigens for lymph node-resident DCs is a gross over-
simpliﬁcation. In fact, viable dermal DCs isolated from the lymph
nodes draining the site of HSV infection have been demonstrated
to stimulate the differentiation of naïve HSV-speciﬁc CD4+ T cells
into effector cells (Bedoui et al., 2009b; Lee et al., 2009). These
HSV-speciﬁc CD4+ T cell responses are not only important for
the resolution of the virus infection in the skin (Gebhardt et al.,
2011), but intriguingly also contribute to the efﬁciency with which
CTLs are primed in a process referred to as “T cell help” (Bevan,
2004). This has been documented by studies showing that the
magnitude of the primary HSV-speciﬁc CTL response following
subcutaneous HSV infection is impaired in the absence of CD4+
T cells (Smith et al., 2004; Rajasagi et al., 2009). Mixed bone mar-
row chimeras revealed that the very same DCs that stimulated the
HSV-speciﬁc CTL response in vivo also needed to receive signals
from cognate CD4+ T cells. With CD8+ DCs being the only DC
subset capable of presenting HSV-derived antigens to CTLs early
in the response and CD8+ DCs also displaying HSV-derived anti-
gens on MHC class II molecules ex vivo (Bedoui et al., 2009b),
the likely scenario is that it is the CD8+ DCs that require T cell
help to efﬁciently prime the CTL response (Figure 3). However,
how exactly CD4+ T cells improve the capacity of CD8+ DCs
to drive the differentiation of the few naïve HSV-speciﬁc CTLs
into fully armed effector cells needs to be examined in more
detail.
Thus, while some migratory DCs, potentially those that are
infected by HSV, can serve as a source of antigens for other
DCs (Carbone et al., 2004), there are also skin-derived DCs in
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the lymph node that have likely obtained HSV-derived antigens
without being productively infected. It is possible that unin-
fected dermal DCs might take up HSV-derived antigens in a
similar manner as lymph node-resident DCs, namely by engulf-
ing debris from dead, infected migratory DCs that have drained
into the lymph node. However, this appears unlikely as skin-
derived DCs mature during their migration from the tissues
to the lymph node and most evidence indicates that mature
DCs have rather poor abilities to take up new antigens (Reis e
Sousa, 2006). What seems more likely is that dermal DCs col-
lect antigens in the skin from infected keratinocytes or other
infected epidermal cells, such as γ/δ-T cells or even other DCs
(Puttur et al., 2010). To account for potential issues related to the
basal membrane at the dermo-epidermal junction physically sep-
arating dermal DCs from infected epidermal cells, it has been
suggested that dermal DCs might obtain antigens from HSV-
infected LCs that die as they transit through the dermis en
route to the lymph node (Cunningham et al., 2010). Whether
this is the dominant way through which dermal DCs obtain
viral antigens in the skin, or whether dermal DCs might be
directly exposed to dead keratinocytes within lytic lesions that
have eroded the dermo-epidermal barrier needs to be investigated.
It is also conceivable that dermal DCs could send protrusions
into the epidermis as has been suggested to occur in the intes-
tine (Rescigno et al., 2001). Any examination of this interesting
question should furthermore take into account that some dermal
DCs have been observed in very close proximity to hair folli-
cles where HSV replicates extensively (Bursch et al., 2007; Eidsmo
et al., 2009) and, that as the lesion size gets larger over time
additional skin-derived DC subsets, such as LCs and CD103+
DCs, also start presenting HSV-derived antigens to CD4+ T
cells in the draining lymph node (Bedoui et al., 2009b). Intrigu-
ingly, in whatever way these migratory DCs gain access to HSV
antigens in the later stages of the infection, CD103+ DCs can
also feed the acquired antigens into the MHC class I pathway
(Bedoui et al., 2009b). The increasing appreciation that lymph
node-resident CD8+ DCs and migratory CD103+ DCs are very
closely related (Crozat et al., 2010b; Bachem et al., 2012) helps
explain why amongst the migratory DCs only the CD103+ DCs
gain the capacity to stimulate naïve HSV-speciﬁc CTLs later in
the response. It remains puzzling, however, why the CD103+
DCs do not participate in the early phase of HSV-speciﬁc CTL
priming. Their late contribution could be related to provid-
ing a second antigenic hit to expanding CTLs before they leave
the lymph node. It is also possible that CD103+ DCs regu-
late tissue-homing capacities of the responding CTLs, as has
been documented in the intestinal immune system (Stock et al.,
2013). Clearly more research is required to delineate the pro-
cesses through which skin-derived and lymph node-resident DCs
obtain HSV antigens and what the consequence of their antigen
presentation is.
ANTIGEN PRESENTATION BY DCs TO
ANTIGEN-EXPERIENCED T CELLS IN INFECTED TISSUES
The above has focused on the role of DCs in the differentiation of
naïve T cells into HSV-speciﬁc effector T cells that subsequently
depart the lymphoid tissues and enter infected sites. Accumulating
evidence suggests that DCs also play an important role in assisting
activated T cells to exert effector functions within primary infected
tissues (Bedoui and Gebhardt, 2011). For example, locally differ-
entiatedMoDCswere recently shown to stimulate IFN-γ secretion
by effector CD4+ T cells inﬁltrating mucosal tissues of vaginally
infected mice (Iijima et al., 2011). A more recent analysis into the
contribution of DCs to local CD4+ T cell and CTL responses fol-
lowing HSV skin infection, made the observation that CD4+ T
cells and CTLs differed substantially in their requirement for DCs
to elicit local effector function (Macleod et al., 2014). While HSV-
speciﬁc CD4+ T cells secreted IFN-γ upon recognizing cognate
antigenonDCs regardless of whether thesewere infectedwithHSV
or not, IFN-γ secretion by HSV-speciﬁc CTLs was only elicited by
infected cells. The latter were predominantly keratinocytes, but
also included DCs and γ/δ-T cells. It will be exciting to exam-
ine the mechanistic basis of why only infected DCs prompted
effector function by HSV-speciﬁc CTLs, while DCs that presented
HSV-derived antigens to naïve CTLs in the lymph node showed
no signs of being infected were protected. How this relates to
reports suggesting that elimination of DCs by effector T cells rep-
resents a negative feedback regulation on T cell priming (Wong
and Pamer, 2003; Yang et al., 2006) should also be investigated by
future work.
CONCLUDING REMARKS
By sensing HSV through pattern recognition receptors, collecting
and delivering HSV-derived antigens to the lymph node, stim-
ulating naïve HSV-speciﬁc T cell responses and contributing at
sites of infection to efﬁcient effector functions by activated T
cells, DCs take center stage in the coordinated innate and adap-
tive immune responses to primary HSV infections. Despite our
growing understanding of the intricate interactions between DCs
and HSV that not only impact on immunity to the primary infec-
tion, but also appear to be of importance in latency (St Leger and
Hendricks, 2011), our abilities to prevent new infections or to
eliminate the virus from infected individuals are still disappoint-
ingly limited (Johnston et al., 2011). Considering the global disease
burden associated with HSV infection and the distinct potential
for severe complications, such as vertically transmitted neonatal
HSV infections, HSV encephalitis or HSV keratitis, more research
is necessary to fully understand how the immune system responds
to HSV infection.
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